SynthesisFrontiers in pharmacology2024

Adjuvant and neoadjuvant therapy with or without CDK4/6 inhibitors in HR+/HER2- early breast cancer: a systematic review and meta-analysis.

Zhihao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.